Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > GPC3

GPC3

Brief Information

Name:Glypican-3
Target Synonym:MXR7,OCI5,GPC3,Glypican-3,Glypican 3,Glypican Proteoglycan 3,GTR2-2,Secreted Glypican-3,OCI-5,SGBS1,DGSX,SGBS,SDYS,SGB,Intestinal protein OCI-5,Heparan Sulphate Proteoglycan
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:45
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
Cat. No. Species Product Description Structure Purity Feature
CHEK-ATP212 Human HEK293/Human GPC3 ΔHS Stable Cell Line
ACRO Quality

Part of Bioactivity data

CHEK-ATP212-Cell-based assay
 GPC3 FACS

Expression analysis of human GPC3 ΔHS on HEK293/Human GPC3 ΔHS Stable Cell Line by FACS.
Cell surface staining was performed on HEK293/Human GPC3 ΔHS Stable Cell Line or negative control cell using PE-labeled anti-human GPC3 antibody.

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
GPC-3298306 GPC-3298306 Phase 2 Clinical National Cancer Center Of Japan Ovarian Neoplasms; Carcinoma, Hepatocellular Details
BOS-342 PRS-342; BOS-342; PRS-342/BOS-342 Phase 2 Clinical Pieris Pharmaceuticals Solid tumours; Carcinoma, Hepatocellular Details
BOXR-1030 BOXR-1030 Phase 2 Clinical Unum Therapeutics Inc Liver Neoplasms; Carcinoma, Merkel Cell; Lung Neoplasms; Carcinoma, Squamous Cell; Liposarcoma, Myxoid; Carcinoma, Hepatocellular Details
AZD-9793 AZD9793; AZD-9793 Phase 2 Clinical Astrazeneca Plc Carcinoma, Hepatocellular Details
CAR-T Cell Therapy Targeting GPC3(Pla General Hospital) Phase 2 Clinical Pla General Hospital Carcinoma, Hepatocellular Details
MRG-006A MRG-006A; MRG-006; MRG006A Phase 2 Clinical Lepu Biopharma Co Ltd, Shanghai Miracogen Inc Solid tumours; Neoplasms; Carcinoma, Hepatocellular Details
C-CAR031 CAR T-cell therapy (AbelZeta) C-CAR031 Phase 2 Clinical Cellular Biomedicine (Shanghai) Co Ltd Carcinoma, Hepatocellular Details
NY-303 NY-303 Phase 2 Clinical NAYA Biosciences Inc Solid tumours; Carcinoma, Hepatocellular Details
AZD-5851 AZD-5851; AZD5851 Phase 2 Clinical Astrazeneca Plc Carcinoma, Hepatocellular Details
SAR-444200 SAR-444200 Phase 2 Clinical Sanofi Solid tumours; Neoplasms Details
CMD-011 CMD-011 Phase 2 Clinical Zhejiang Shimai Pharmaceutical Co Ltd Liver Neoplasms; Carcinoma, Hepatocellular Details
CAR-GPC3 T-cell (Drum Tower Hospital) Phase 2 Clinical Nanjing Drum Tower Hospital Carcinoma, Hepatocellular Details
GPC3 CAR-T therapy (Hrain Biotechnology) Phase 2 Clinical Hrain Biotechnology Co Ltd Carcinoma, Hepatocellular Details
CM-350 CM-350 Phase 2 Clinical Keymed Biosciences Co Ltd Solid tumours Details
GPC3-CAR-T cell therapy(Origincell Medical Technology) Ori-CAR-001; Ori-C101(OriCell) Phase 2 Clinical OriCell Therapeutics Co Ltd Carcinoma, Hepatocellular Details
ECT-204 JWATM-204; ECT-204 Phase 2 Clinical Eureka Therapeutics Inc, Jw Therapeutics (Shanghai) Co Ltd Liver Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung Details
Codrituzumab GC-33; RG-7686; RO-5137382 Phase 1 Clinical Chugai Pharmaceutical Co Ltd, F. Hoffmann-La Roche Ltd Solid tumours; Carcinoma, Hepatocellular Details
GPC3-T2 CAR-T cell therapy (The Second Affiliated Hospital of Guangzhou Medical University) Phase 1 Clinical Second Affiliated Hospital Of Guangzhou Medical University Carcinoma, Squamous Cell; Carcinoma, Hepatocellular Details
GLYCAR T cell therapy (Baylor College of Medicine) GLYCAR Phase 1 Clinical Baylor College Of Medicine Rhabdomyosarcoma; Liver Neoplasms; Hepatoblastoma; Rhabdoid Tumor; Wilms Tumor; Liposarcoma; Carcinoma, Hepatocellular; Endodermal Sinus Tumor Details
Anti-GPC3 CAR T-cell therapy (Carbiogene Therapeutics) CBG166; CBG-166 Phase 1 Clinical Nanjing University, Carbiogene Therapeutics Co Ltd Carcinoma, Hepatocellular Details
GPC3-CAR-T cell therapy CSG-GPC-3; CAR-GPC3 T-cell; GPC3-CAR/CSG-GPC3; anti-GPC-3 CAR T; KJgpc3-001; CT-011 Phase 1 Clinical Carsgen Biomedicine (Shanghai) Co Ltd Solid tumours; Carcinoma, Squamous Cell; Carcinoma, Hepatocellular Details
Anti-GPC3 chimeric antigen receptor T cell therapy (Hunan Zhaotai Yongren Biotech/Guangdong Zhaotai Invivo Biomedicine) Phase 1 Clinical Hunan Zhaotai Yongren Biotech Co Ltd, Guangdong Zhaotai Invivo Biomedicine Co Ltd Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung Details
GPC3-T2-CAR-T GPC3-T2-CAR-T Phase 1 Clinical Second Affiliated Hospital Of Guangzhou Medical University Carcinoma, Hepatocellular Details
EU-307 EU307 Phase 1 Clinical Eutilex Liver Neoplasms; Carcinoma, Hepatocellular Details
Ori-CAR-002 Ori-CAR-002; GPC3-CAR-Ori2 Phase 1 Clinical OriCell Therapeutics Co Ltd Multiple Myeloma Details
SENTI-301 SENTI-301; SENTI-301A; SN301A Phase 1 Clinical Senti Biosciences Inc Liver Neoplasms; Carcinoma, Hepatocellular Details
MT-303(Myeloid) MT-303(Myeloid) Phase 1 Clinical Myeloid Therapeutics Inc Carcinoma, Hepatocellular Details
68Ga-aGPC3-scFv/Fab 68Ga-aGPC3-scFv/Fab Phase 1 Clinical Wuhan Union Hospital Liver Neoplasms Details
BGB-B2033 BGB-B2033; BGB-B-2033 Phase 1 Clinical Beigene Guangzhou Biologics Manufacturing Co Ltd Solid tumours; Stomach Neoplasms; Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis Details
BC-2027 BC2027; BC-2027 Phase 1 Clinical Wuxi BioCity Liver Neoplasms; Solid tumours Details
JMT-106 JMT106; JMT-106 Phase 1 Clinical CSPC Pharmaceutical Group Ltd Solid tumours Details
AST-201 (Aptamer Sciences) AST-201(Aptamer Sciences) Phase 1 Clinical Aptamer Sciences Inc Liver Neoplasms; Solid tumours; Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung Details
GPC3/Mesothelin-CAR-γδT Cells therapy(Second Affiliated Hospital Of Guangzhou Medical University) Phase 1 Clinical Second Affiliated Hospital Of Guangzhou Medical University Solid tumours; Liver Neoplasms; Pancreatic Neoplasms; Mesothelioma; Lung Neoplasms Details
RYZ-801 RYZ-801(225Ac); RYZ-801; ABZ-706; 225Ac-GPC3 Phase 1 Clinical PeptiDream Inc, RayzeBio Inc Carcinoma, Hepatocellular Details
NWRD-06 NWRD-06; NWRD06 Phase 1 Clinical Newish Technology (Beijing) Co Ltd Carcinoma, Hepatocellular Details
GPC3-targeted CAR-T (Peking University) Phase 1 Clinical Peking University Carcinoma, Hepatocellular Details
CAR (hYP7)-T cells (National Cancer Institute) Phase 1 Clinical National Cancer Institute Carcinoma, Hepatocellular Details
TC-CAR-031 C-CAR-031; TC-CAR-031; TC-CAR031; C-CAR031 Phase 1 Clinical Zhejiang University, Cellular Biomedicine Group Inc Carcinoma, Hepatocellular Details
IM-83 CAR-T cell therapy IM-83; IM83 Phase 1 Clinical Beijing Immunochina Medical Science & Technology Co Ltd Liver Neoplasms; Neoplasms; Osteosarcoma; Carcinoma, Hepatocellular Details
CT-017 CT-017 Phase 1 Clinical Carsgen Biomedicine (Shanghai) Co Ltd Carcinoma, Hepatocellular Details
JWATM-214 JWATM-214; JWATM214 Phase 1 Clinical Suzhou Yaomingjunuo Biotechnology Co Ltd Liver Neoplasms; Carcinoma, Hepatocellular Details
TH-012(Bangentai Biomedical) TH-012 Phase 1 Clinical Shandong Bangentai Biomedical Tech Group Co Ltd Stomach Neoplasms; Pancreatic Neoplasms Details
B010-A B010-A Phase 1 Clinical Shanghai Pharmaceuticals Holding Co Ltd Carcinoma, Hepatocellular Details
CT-0180 CT-0180 Phase 1 Clinical CARsgen Therapeutics Holdings Ltd Carcinoma, Hepatocellular Details
ERY-974 ERY-974 Phase 1 Clinical Chugai Pharmaceutical Co Ltd Solid tumours; Carcinoma, Hepatocellular Details
TAK-102 TAK-102; NIB-102 Phase 1 Clinical Noile-Immune Biotech Inc Solid tumours Details
HRAIN-011 HRAIN-011 Clinical Hrain Biotechnology Co Ltd Carcinoma, Hepatocellular Details
Anti-GPC3-IRDye800CW Clinical Chinese Academy Of Sciences Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message